Methicillin-resistant Staphylococcus aureus: a community concern

S D Med. 2006 Oct;59(10):433, 435.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use
  • Clindamycin / pharmacology
  • Clindamycin / therapeutic use
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / prevention & control
  • Community-Acquired Infections / transmission
  • Doxycycline / pharmacology
  • Doxycycline / therapeutic use
  • Humans
  • Methicillin Resistance*
  • Minocycline / pharmacology
  • Minocycline / therapeutic use
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / prevention & control
  • Staphylococcal Infections / transmission
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / isolation & purification
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Clindamycin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Minocycline
  • Doxycycline